210 related articles for article (PubMed ID: 36675584)
1. Autoantibodies and Clinical Correlations in Polish Systemic Sclerosis Patients: A Cross-Sectional Study.
Żebryk P; Przymuszała P; Nowak JK; Piorunek T; Mularek-Kubzdela T; Puszczewicz M
J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675584
[TBL] [Abstract][Full Text] [Related]
2. Serological profile of patients with systemic sclerosis.
Wielosz E; Dryglewska M; Majdan M
Postepy Hig Med Dosw (Online); 2014 Aug; 68():987-91. PubMed ID: 25228505
[TBL] [Abstract][Full Text] [Related]
3. A cross-sectional study of autoantibody profiles in the Waikato systemic sclerosis cohort, New Zealand.
Chang WS; Schollum J; White DH; Solanki KK
Clin Rheumatol; 2015 Nov; 34(11):1921-7. PubMed ID: 26022620
[TBL] [Abstract][Full Text] [Related]
4. Autoantibody profiles in systemic sclerosis; a comparison of diagnostic tests.
Alkema W; Koenen H; Kersten BE; Kaffa C; Dinnissen JWB; Damoiseaux JGMC; Joosten I; Driessen-Diks S; van der Molen RG; Vonk MC; Smeets RL
Autoimmunity; 2021 May; 54(3):148-155. PubMed ID: 33818234
[TBL] [Abstract][Full Text] [Related]
5. Antinuclear antibody pattern and autoantibody profiling of systemic sclerosis patients in a tertiary referral center in North India.
Machhua S; Sharma SK; Kumar Y; Anand S; Handa S; Minz RW
Pathol Int; 2022 May; 72(5):283-292. PubMed ID: 35319814
[TBL] [Abstract][Full Text] [Related]
6. Capillaroscopy and Immunological Profile in Systemic Sclerosis.
Lambova SN; Kurteva EK; Dzhambazova SS; Vasilev GH; Kyurkchiev DS; Geneva-Popova MG
Life (Basel); 2022 Mar; 12(4):. PubMed ID: 35454989
[TBL] [Abstract][Full Text] [Related]
7. Multiparametric autoantibody profiling of patients with systemic sclerosis in Greece.
Liaskos C; Marou E; Simopoulou T; Gkoutzourelas A; Barmakoudi M; Efthymiou G; Scheper T; Meyer W; Katsiari CG; Bogdanos DP; Sakkas LI
Mediterr J Rheumatol; 2018 Sep; 29(3):120-126. PubMed ID: 32185313
[TBL] [Abstract][Full Text] [Related]
8. Disease-related autoantibody profile in patients with systemic sclerosis.
Liaskos C; Marou E; Simopoulou T; Barmakoudi M; Efthymiou G; Scheper T; Meyer W; Bogdanos DP; Sakkas LI
Autoimmunity; 2017 Nov; 50(7):414-421. PubMed ID: 28749191
[TBL] [Abstract][Full Text] [Related]
9. Clinical phenotype in scleroderma patients based on autoantibodies.
Santos CS; Morales CM; Castro CÁ; Álvarez ED
Rheumatol Adv Pract; 2023 Apr; 7(Suppl 1):i26-i33. PubMed ID: 36968636
[TBL] [Abstract][Full Text] [Related]
10. [Autoantibodies in systemic sclerosis].
Żebryk P; Puszczewicz M
Postepy Hig Med Dosw (Online); 2015 May; 69():654-60. PubMed ID: 26035026
[TBL] [Abstract][Full Text] [Related]
11. Autoantibody profile in a cohort of Algerian patients with systemic sclerosis.
Tahiat A; Allam I; Abdessemed A; Mellal Y; Nebbab R; Ladjouze-Rezig A; Djidjik R
Ann Biol Clin (Paris); 2020 Apr; 78(2):126-133. PubMed ID: 32175889
[TBL] [Abstract][Full Text] [Related]
12. The prevalence and significance of anti-PM/Scl antibodies in systemic sclerosis.
Wielosz E; Dryglewska M; Majdan M
Ann Agric Environ Med; 2021 Mar; 28(1):189-192. PubMed ID: 33775087
[TBL] [Abstract][Full Text] [Related]
13. Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers.
Cavazzana I; Vojinovic T; Airo' P; Fredi M; Ceribelli A; Pedretti E; Lazzaroni MG; Garrafa E; Franceschini F
Clin Rev Allergy Immunol; 2023 Jun; 64(3):412-430. PubMed ID: 35716254
[TBL] [Abstract][Full Text] [Related]
14. Clinical and laboratory features of African-Brazilian patients with systemic sclerosis.
Mendes C; Viana VST; Pasoto SG; Leon EP; Bonfa E; Sampaio-Barros PD
Clin Rheumatol; 2020 Jan; 39(1):9-17. PubMed ID: 31065858
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a commercial immunoassay for autoantibodies in Chinese Han systemic sclerosis population.
Liu C; Hou Y; Yang Y; Xu D; Li L; Li J; Wen X; Zeng X; Zhang F; Li Y
Clin Chim Acta; 2019 Apr; 491():121-125. PubMed ID: 30685360
[TBL] [Abstract][Full Text] [Related]
16. Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis.
Patterson KA; Roberts-Thomson PJ; Lester S; Tan JA; Hakendorf P; Rischmueller M; Zochling J; Sahhar J; Nash P; Roddy J; Hill C; Nikpour M; Stevens W; Proudman SM; Walker JG
Arthritis Rheumatol; 2015 Dec; 67(12):3234-44. PubMed ID: 26246178
[TBL] [Abstract][Full Text] [Related]
17. Antibodies against specific extractable nuclear antigens (ENAs) as diagnostic and prognostic tools and inducers of a profibrotic phenotype in cultured human skin fibroblasts: are they functional?
Corallo C; Cheleschi S; Cutolo M; Soldano S; Fioravanti A; Volpi N; Franci D; Nuti R; Giordano N
Arthritis Res Ther; 2019 Jun; 21(1):152. PubMed ID: 31234888
[TBL] [Abstract][Full Text] [Related]
18. Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais.
Foocharoen C; Watcharenwong P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R
Int J Rheum Dis; 2017 Oct; 20(10):1572-1581. PubMed ID: 28296274
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy and predictive value of autoantibody profiles in patients with systemic sclerosis: a single-center study.
Zhang X; Zhang H; Zhao J; Li Y; Wang H; Li C
Clin Rheumatol; 2023 May; 42(5):1297-1306. PubMed ID: 36604358
[TBL] [Abstract][Full Text] [Related]
20. Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients.
Hanke K; Brückner CS; Dähnrich C; Huscher D; Komorowski L; Meyer W; Janssen A; Backhaus M; Becker M; Kill A; Egerer K; Burmester GR; Hiepe F; Schlumberger W; Riemekasten G
Arthritis Res Ther; 2009; 11(1):R22. PubMed ID: 19220911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
